Dow Up0.10% Nasdaq Up0.06%

Corcept Therapeutics Incorporated (CORT)

-NasdaqCM
3.00 Down 0.01(0.33%) 10:20AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 10,357   3,307   -  
Cost of Revenue143  91   -  
Gross Profit 10,214   3,216   -  
Operating Expenses
Research Development20,470  14,074  21,001  
Selling General and Administrative31,240  25,414  11,331  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (41,496) (36,272) (32,332)
Income from Continuing Operations
Total Other Income/Expenses Net -   -  3  
Earnings Before Interest And Taxes(41,496)(36,272)(32,329)
Interest Expense4,515  1,776  25  
Income Before Tax(46,011)(38,048)(32,354)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(46,011)(38,048)(32,354)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (46,011) (38,048) (32,354)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (46,011) (38,048) (32,354)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.